Combining our findings that cdk6-deficient cancer cells lost ABCB1-mediated MDR via co-downregulating PI3K 110α/β, we deem that cdk6 could be a promising target for reversing ABCB1-mediated MDR and inhibiting cancer cell proliferation simultaneously. Here, PIK3CB is linked to cancer.